S. Bak Mueller

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors.

B. Roth, T. Bocan, D. Sliskovic, 1992, Biochimica et biophysica acta.

The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression.

B. Auerbach, T. Bocan, W. Rosebury, 2001, Atherosclerosis.

HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit.

T. Rea, M. Pape, T. Bocan, 1998, Atherosclerosis.

The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation.

T. Bocan, M. J. Mazur, S. Mueller, 1993, Atherosclerosis.